|

MNPR-101-DFO*-89Zr Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Monopar Therapeutics1

Indications

  • Urothelial Carcinoma1
  • Triple Negative Breast Cancer1
  • Pancreatic Cancer1
  • Bladder Cancer1
  • Ovarian Cancer1

Other1 trial

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.